Works matching IS 0741238X AND DT 2022 AND VI 39 AND IP 6
Results: 55
Efficacy and Safety of Intravitreal Aflibercept Treat-and-Extend Regimens in the ALTAIR Study: 96-Week Outcomes in the Polypoidal Choroidal Vasculopathy Subgroup.
- Published in:
- Advances in Therapy, 2022, v. 39, n. 6, p. 2984, doi. 10.1007/s12325-022-02162-w
- By:
- Publication type:
- Article
Cost-Effectiveness of Linaclotide Compared to Osmotic Laxatives in the Treatment of Irritable Bowel Syndrome with Constipation in China.
- Published in:
- Advances in Therapy, 2022, v. 39, n. 6, p. 2971, doi. 10.1007/s12325-022-02161-x
- By:
- Publication type:
- Article
High Expression of C8orf76 Is an Independent Predictive Factor of Poor Prognosis in Patients with Breast Cancer.
- Published in:
- Advances in Therapy, 2022, v. 39, n. 6, p. 2946, doi. 10.1007/s12325-022-02159-5
- By:
- Publication type:
- Article
Iron Deficiency in Women's Health: New Insights into Diagnosis and Treatment.
- Published in:
- Advances in Therapy, 2022, v. 39, n. 6, p. 2438, doi. 10.1007/s12325-022-02157-7
- By:
- Publication type:
- Article
Efficacy of GLP-1 RA Approved for Weight Management in Patients With or Without Diabetes: A Narrative Review.
- Published in:
- Advances in Therapy, 2022, v. 39, n. 6, p. 2452, doi. 10.1007/s12325-022-02153-x
- By:
- Publication type:
- Article
17-Year Follow-up of Comparing Mastoscopic and Conventional Axillary Dissection in Breast Cancer: A Multicenter, Randomized Controlled Trial.
- Published in:
- Advances in Therapy, 2022, v. 39, n. 6, p. 2961, doi. 10.1007/s12325-022-02152-y
- By:
- Publication type:
- Article
Changes in Refractive Error Under COVID-19: A 3-Year Follow-up Study.
- Published in:
- Advances in Therapy, 2022, v. 39, n. 6, p. 2999, doi. 10.1007/s12325-022-02150-0
- By:
- Publication type:
- Article
One-Year Sequelae and Quality of Life in Adults with Meningococcal Meningitis: Lessons from the COMBAT Multicentre Prospective Study.
- Published in:
- Advances in Therapy, 2022, v. 39, n. 6, p. 3031, doi. 10.1007/s12325-022-02149-7
- By:
- Publication type:
- Article
Correction to: The Economic Burden of Insulin Injection-Induced Lipohypertrophy. Role of Education: The ISTERP-3 Study.
- Published in:
- 2022
- By:
- Publication type:
- Correction Notice
Inflammatory Bowel Disease Patients' Treatment Preferences Using a Discrete Choice Experiment Technique: The InPuT Study.
- Published in:
- Advances in Therapy, 2022, v. 39, n. 6, p. 2889, doi. 10.1007/s12325-022-02143-z
- By:
- Publication type:
- Article
Association Between Granulocyte Colony-Stimulating Factor (G-CSF) Use and Myelodysplastic Syndrome (MDS) or Acute Myeloid Leukemia (AML) Among Elderly Patients with Breast, Lung, or Prostate Cancer.
- Published in:
- Advances in Therapy, 2022, v. 39, n. 6, p. 2778, doi. 10.1007/s12325-022-02141-1
- By:
- Publication type:
- Article
Enzalutamide in Chemotherapy-Naïve Metastatic Castration-Resistant Prostate Cancer: An Asian Multiregional, Randomized Study.
- Published in:
- Advances in Therapy, 2022, v. 39, n. 6, p. 2641, doi. 10.1007/s12325-022-02140-2
- By:
- Publication type:
- Article
Clinical and Genetic Evaluation of People with or at Risk of Hereditary ATTR Amyloidosis: An Expert Opinion and Consensus on Best Practice in Ireland and the UK.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Efficacy of IDegLira Versus IDegAsp Therapy in Patients with Type 2 Diabetes: A Randomized Crossover Study by isCGM.
- Published in:
- Advances in Therapy, 2022, v. 39, n. 6, p. 2688, doi. 10.1007/s12325-022-02138-w
- By:
- Publication type:
- Article
Baseline Characteristics and Treatment Response to Ixekizumab Categorised by Sex in Radiographic and Non-radiographic Axial Spondylarthritis Through 52 Weeks: Data from Three Phase III Randomised Controlled Trials.
- Published in:
- Advances in Therapy, 2022, v. 39, n. 6, p. 2806, doi. 10.1007/s12325-022-02132-2
- By:
- Publication type:
- Article
Advances in Clinical Cardiology 2021: A Summary of Key Clinical Trials.
- Published in:
- Advances in Therapy, 2022, v. 39, n. 6, p. 2398, doi. 10.1007/s12325-022-02136-y
- By:
- Publication type:
- Article
Unmet Needs of Glycaemic Control and Risk Factors of Residual Hyperglycaemia in a Chinese Population with Type 2 Diabetes Initiating Basal Insulin: A Post Hoc Analysis of the FPG GOAL Study.
- Published in:
- Advances in Therapy, 2022, v. 39, n. 6, p. 2820, doi. 10.1007/s12325-022-02128-y
- By:
- Publication type:
- Article
Use of Perindopril Arginine/Indapamide/Amlodipine in the Management of Hypertension in Two Sub-Saharan African Island Countries of Madagascar and Mauritius.
- Published in:
- Advances in Therapy, 2022, v. 39, n. 6, p. 2850, doi. 10.1007/s12325-022-02134-0
- By:
- Publication type:
- Article
Proposal for a New Protocol for the Management of Immune Thrombocytopenia (ITP).
- Published in:
- Advances in Therapy, 2022, v. 39, n. 6, p. 2287, doi. 10.1007/s12325-022-02133-1
- By:
- Publication type:
- Article
Quality Standard Position Statements for Health System Policy Changes in Diagnosis and Management of COPD: A Global Perspective.
- Published in:
- Advances in Therapy, 2022, v. 39, n. 6, p. 2302, doi. 10.1007/s12325-022-02137-x
- By:
- Publication type:
- Article
Is Liver Transplant Curative in Homozygous Familial Hypercholesterolemia? A Review of Nine Global Cases.
- Published in:
- Advances in Therapy, 2022, v. 39, n. 6, p. 3042, doi. 10.1007/s12325-022-02131-3
- By:
- Publication type:
- Article
Efficacy and Safety of ELOM-080 as Add-On Therapy in COVID-19 Patients with Acute Respiratory Insufficiency: Exploratory Data from the Prospective Placebo-Controlled COVARI Trial.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Correction to: Patterns of Use and Clinical Outcomes with Long-Acting Somatostatin Analogues for Neuroendocrine Tumors: A Nationwide French Retrospective Cohort Study in the Real-Life Setting.
- Published in:
- 2022
- By:
- Publication type:
- Correction Notice
Ixekizumab Citrate-Free Formulation: Results from Two Clinical Trials.
- Published in:
- Advances in Therapy, 2022, v. 39, n. 6, p. 2862, doi. 10.1007/s12325-022-02126-0
- By:
- Publication type:
- Article
Reduced Progression of Monoclonal Gammopathy of Undetermined Significance to Multiple Myeloma in Type 2 Diabetes Mellitus: Will Metformin Never Stop Its Pleasant Surprises?
- Published in:
- 2022
- By:
- Publication type:
- Editorial
Treatment Goals for Psoriasis as Measured by Patient Benefit Index: Results of a National Psoriasis Foundation Survey.
- Published in:
- Advances in Therapy, 2022, v. 39, n. 6, p. 2657, doi. 10.1007/s12325-022-02124-2
- By:
- Publication type:
- Article
Cost-Effectiveness of Treating Patients with Chronic Kidney Disease and Prior Hyperkalemia with Renin-Angiotensin-Aldosterone System Inhibitor and Patiromer: A Swiss Public Healthcare Perspective.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Real-World Data Analysis of Second-Line Antiangiogenic Targeted Treatments Following Anti-Epidermal Growth Factor Receptor Monoclonal Antibodies and First-Line FOLFOX for Patients with Metastatic Colorectal Cancer.
- Published in:
- Advances in Therapy, 2022, v. 39, n. 6, p. 2596, doi. 10.1007/s12325-022-02122-4
- By:
- Publication type:
- Article
The Durable Safety and Effectiveness of Lixisenatide in Japanese People with Type 2 Diabetes: The Post-Marketing Surveillance PRANDIAL Study.
- Published in:
- Advances in Therapy, 2022, v. 39, n. 6, p. 2873, doi. 10.1007/s12325-022-02121-5
- By:
- Publication type:
- Article
Mesenchymal Stem Cell Therapy Awareness, Knowledge, and Use for the Treatment of Fistulizing Crohn's Disease: An International Survey Among Gastroenterologists and Colorectal Surgeons.
- Published in:
- Advances in Therapy, 2022, v. 39, n. 6, p. 2761, doi. 10.1007/s12325-022-02113-5
- By:
- Publication type:
- Article
Epidemiology and Economic Burden of Atopic Dermatitis: Real-World Retrospective Data from a Large Nationwide Israeli Healthcare Provider Database.
- Published in:
- Advances in Therapy, 2022, v. 39, n. 6, p. 2502, doi. 10.1007/s12325-022-02120-6
- By:
- Publication type:
- Article
Menstrual Symptoms, Health-Related Quality of Life, and Work Productivity in Japanese Women with Dysmenorrhea Receiving Different Treatments: Prospective Observational Study.
- Published in:
- Advances in Therapy, 2022, v. 39, n. 6, p. 2562, doi. 10.1007/s12325-022-02118-0
- By:
- Publication type:
- Article
Disease Progression Stages and Burden in Patients with Duchenne Muscular Dystrophy Using Administrative Claims Supplemented by Electronic Medical Records.
- Published in:
- Advances in Therapy, 2022, v. 39, n. 6, p. 2906, doi. 10.1007/s12325-022-02117-1
- By:
- Publication type:
- Article
Clinicopathologic Characteristics and Prognosis of PDGFRA-Mutant Gastrointestinal Stromal Tumors: A Large-Scale, Multi-Institutional, Observational Study in China.
- Published in:
- Advances in Therapy, 2022, v. 39, n. 6, p. 2920, doi. 10.1007/s12325-022-02115-3
- By:
- Publication type:
- Article
What Are Realistic Expectations to Become Free of Overactive Bladder Symptoms? Experience from Non-interventional Studies with Propiverine.
- Published in:
- Advances in Therapy, 2022, v. 39, n. 6, p. 2489, doi. 10.1007/s12325-022-02114-4
- By:
- Publication type:
- Article
Dosing Regimens of Intravitreal Aflibercept for Diabetic Macular Edema Beyond the First Year: VIOLET, a Prospective Randomized Trial.
- Published in:
- Advances in Therapy, 2022, v. 39, n. 6, p. 2701, doi. 10.1007/s12325-022-02119-z
- By:
- Publication type:
- Article
Treatment Patterns Among Patients with Bipolar Disorder in the United States: A Retrospective Claims Database Analysis.
- Published in:
- Advances in Therapy, 2022, v. 39, n. 6, p. 2578, doi. 10.1007/s12325-022-02112-6
- By:
- Publication type:
- Article
Adherence to Subcutaneous Interferon Beta-1a in Multiple Sclerosis Patients Receiving Periodic Feedback on Drug Use by Discussion of Readouts of Their Rebismart<sup>®</sup> Injector: Results of the Prospective Cohort Study REBIFLECT.
- Published in:
- Advances in Therapy, 2022, v. 39, n. 6, p. 2749, doi. 10.1007/s12325-022-02100-w
- By:
- Publication type:
- Article
Recommendations from a Working Group on Obesity Care Competencies for Healthcare Education in the UK: A Report by the Steering Committee.
- Published in:
- Advances in Therapy, 2022, v. 39, n. 6, p. 3019, doi. 10.1007/s12325-022-02108-2
- By:
- Publication type:
- Article
Occurrence and Prognosis of Secondary Lung Cancer in Patients with Primary Nasal Cavity and Sinus Squamous Cell Carcinoma.
- Published in:
- Advances in Therapy, 2022, v. 39, n. 6, p. 2533, doi. 10.1007/s12325-022-02107-3
- By:
- Publication type:
- Article
Observational Study in a Real-World Setting of Targeted Therapy in the Systemic Treatment of Progressive Unresectable or Metastatic Well-Differentiated Pancreatic Neuroendocrine Tumors (pNETs) in France: OPALINE Study.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Pembrolizumab Plus Chemotherapy as First-Line Treatment for Advanced Esophageal Cancer: A Cost-Effectiveness Analysis.
- Published in:
- Advances in Therapy, 2022, v. 39, n. 6, p. 2614, doi. 10.1007/s12325-022-02101-9
- By:
- Publication type:
- Article
Improving Care in Eosinophil-Associated Diseases: A Charter.
- Published in:
- Advances in Therapy, 2022, v. 39, n. 6, p. 2323, doi. 10.1007/s12325-022-02110-8
- By:
- Publication type:
- Article
"I Can't Take off My Shirt or Do My Own Hair"—A Qualitative Investigation of the Symptoms and Impact Experience of Children and Adolescents with Fibrodysplasia Ossificans Progressiva (FOP).
- Published in:
- Advances in Therapy, 2022, v. 39, n. 6, p. 2796, doi. 10.1007/s12325-022-02096-3
- By:
- Publication type:
- Article
Tafasitamab Plus Lenalidomide Versus 3 Rituximab-Based Treatments for Non-Transplant Eligible Relapsed/Refractory Diffuse Large B-Cell Lymphoma: A Matching-Adjusted Indirect Comparison.
- Published in:
- Advances in Therapy, 2022, v. 39, n. 6, p. 2668, doi. 10.1007/s12325-022-02094-5
- By:
- Publication type:
- Article
Analysis of a Real-World Progression Variable and Related Endpoints for Patients with Five Different Cancer Types.
- Published in:
- Advances in Therapy, 2022, v. 39, n. 6, p. 2831, doi. 10.1007/s12325-022-02091-8
- By:
- Publication type:
- Article
Real-World Treatment Patterns After CD19-Directed CAR T Cell Therapy Among Patients with Diffuse Large B Cell Lymphoma.
- Published in:
- Advances in Therapy, 2022, v. 39, n. 6, p. 2630, doi. 10.1007/s12325-022-02087-4
- By:
- Publication type:
- Article
Health Care Resource Utilization and Costs Associated with Disease Progression in Ovarian Cancer.
- Published in:
- Advances in Therapy, 2022, v. 39, n. 6, p. 2544, doi. 10.1007/s12325-022-02086-5
- By:
- Publication type:
- Article
Real-World Effectiveness of Sipuleucel-T on Overall Survival in Men with Advanced Prostate Cancer Treated with Androgen Receptor-Targeting Agents.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Early Real-World Experience of Tofacitinib for Psoriatic Arthritis: Data from a United States Healthcare Claims Database.
- Published in:
- Advances in Therapy, 2022, v. 39, n. 6, p. 2932, doi. 10.1007/s12325-022-02084-7
- By:
- Publication type:
- Article